0001437749-17-015570.txt : 20170905
0001437749-17-015570.hdr.sgml : 20170905
20170905160500
ACCESSION NUMBER: 0001437749-17-015570
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170901
FILED AS OF DATE: 20170905
DATE AS OF CHANGE: 20170905
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KLOSK STEVEN M
CENTRAL INDEX KEY: 0001192621
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10638
FILM NUMBER: 171068772
MAIL ADDRESS:
STREET 1: C/O CAMBREX CORP
STREET 2: ONE MEADOWLANDS PLZ
CITY: EAST RUTHERFORD
STATE: NJ
ZIP: 07073
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CAMBREX CORP
CENTRAL INDEX KEY: 0000820081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222476135
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MEADOWLANDS PLZ
CITY: E RUTHERFORD
STATE: NJ
ZIP: 07073
BUSINESS PHONE: 2018043000
MAIL ADDRESS:
STREET 1: ONE MEADOWLANDS PLAZA
CITY: E. RUTHERFORD
STATE: NJ
ZIP: 07073
4
1
rdgdoc.xml
FORM 4
X0306
4
2017-09-01
0000820081
CAMBREX CORP
CBM
0001192621
KLOSK STEVEN M
ONE MEADOWLANDS PLAZA
EAST RUTHERFORD
NJ
07073
1
1
President & CEO
Common Stock
2017-09-01
4
M
0
12000
5.72
A
95328
D
Common Stock
2017-09-01
4
S
0
10702
51.4658
D
84626
D
Common Stock
2017-09-01
4
S
0
1298
52.0802
D
83328
D
Stock Option (right to buy)
5.72
2017-09-01
4
M
0
12000
0
A
2018-10-18
Common Stock
12000
4000
D
The exercise of stock options and sale of corresponding shares reported herein was carried out pursuant to a plan adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.00 to $51.95 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 2 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.00 to $52.2500 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 3 to this Form 4.
The option representing a right to purchase 100,000 shares became exercisable in four equal installments beginning October 18, 2012, which was the first anniversary of the date on which the option was granted.
/s/ Danielle Mann for Steven Klosk by POA
2017-09-05